T 0739/01 (NSAID for dementia/UNIVERSITY OF BRITISH COLUMBIA) of 6.10.2005

European Case Law Identifier: ECLI:EP:BA:2005:T073901.20051006
Date of decision: 06 October 2005
Case number: T 0739/01
Application number: 92910600.3
IPC class: A61K 31/00
Language of proceedings: EN
Distribution: B
Download and more information:
Decision text in EN (PDF, 78 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Use of NSAID in the treatment of dementia
Applicant name: University of British Columbia
Opponent name: Merck & Co., Inc.
Monsanto Company
Board: 3.3.02
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 123(2)
European Patent Convention 1973 Art 54(2)
Keywords: Disclaimer (not accepted): No accidental anticipation
Catchwords:

With respect to the admissibility of disclaimers, it does not matter if the skilled person finds reasons in the relevant prior-art document that make him believe that the particular novelty-destroying embodiment in the context of the citation appears accidental. As long as the document in which this embodiment is set out relates to the same technical field as the alleged invention, the anticipation is related and not remote.

Cited decisions:
G 0001/03
Citing decisions:
T 1911/08

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010739eu1.html

Date retrieved: 17 May 2021

3 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law